Cancer by the Numbers
Cancer in data: the global scale of the disease, and the quieter good-news story of how much survival has improved since the 1970s.
December 3, 2025 · By The Editors, Healing Stories Network · 2 min read
Cancer is among the most feared words in medicine, and the global numbers are sobering. Yet alongside the scale of the disease sits one of the quieter good-news stories in health: for many cancers, survival has improved markedly over the past half century. This post looks at both sides of the data.
This is a data companion piece, not medical advice. The figures describe populations and are approximate; any personal concern belongs with a qualified clinician who knows your history.
The global scale
The World Health Organization and its cancer agency estimate that there were around 20 million new cancer cases worldwide in a recent year, with close to 10 million deaths. Roughly one in five people will develop cancer at some point in their lifetime.
Which cancers are most common
A handful of cancers account for much of the global total. Breast, lung, and colorectal cancers are among the most commonly diagnosed worldwide, with prostate cancer also high among men. Lung cancer remains the leading cause of cancer death, reflecting both how common it is and how hard it can be to catch early. The patterns differ by region, sex, and age.
Survival has improved
One of the most encouraging trends is the rise in survival. In the United States, the five-year survival rate across cancers has climbed substantially since the 1970s, helped by earlier detection and better treatment, though it varies enormously by cancer type.
Why survival has improved
The gains in survival come from several directions at once. Screening programmes catch some cancers earlier, when they are more treatable. Treatment has advanced from surgery, chemotherapy, and radiation alone to include targeted drugs and immunotherapies that work with the immune system. Not every cancer has benefited equally, and some remain very hard to treat, but the overall trajectory for many common types has been upward.
Why the numbers matter
The scale explains why screening, early detection, and research receive such emphasis, while the survival trend is a reminder that a diagnosis today is not what it was a generation ago. Outcomes still differ greatly between cancers and between countries, but the overall direction, for many types, has been one of progress.
A meaningful share of cancers are linked to factors that can be influenced at a population level, including tobacco, certain infections, and other exposures, which is why prevention and vaccination sit alongside treatment in the wider picture. For the individual, though, a diagnosis is rarely about any single cause, and the more useful focus is on detection, care, and support.
For the human side, see our companion pieces on the first week after a cancer diagnosis, prostate cancer, and mRNA cancer vaccines, or browse our Cancer Journeys collection.
About these figures: The statistics here are approximate and drawn largely from World Health Organization and cancer-registry estimates. They are revised regularly and vary by type, country, and methodology, so treat them as a sense of scale and consult the original sources for current numbers. This article is general information, not medical advice.
This article is a companion, not medical advice. Any personal concern about cancer belongs with a qualified clinician.
The Reading Room publishes personal stories and editorial notes from our press. Everything here is companion reading — never medical advice, diagnosis, or treatment. For guidance about your own health, please speak with a qualified clinician.